The anti-tumour effects of metformin have been shown to be dependent on such AMPK activation [22-25], however antineoplastic effects may also be independent of AMPK activation with, for example, altered NF-kB signalling being implicated [26]. The gene discussed is PRKAA1; the disease is neoplasm.